Telangiectatic osteosarcoma: a review of 87 cases (Q38911783)

7 September 2017

title

Telangiectatic osteosarcoma: a review of 87 cases (English)

1 reference

7 September 2017

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27469493%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Pietro Ruggieri

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27469493%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

author name string

Andreas F Mavrogenis

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27469493%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Giulia Trovarelli

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27469493%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Stefano Ferrari

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27469493%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Piero Picci

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27469493%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

publication date

28 July 2016

1 reference

Journal of Cancer Research and Clinical Oncology

7 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27469493%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

volume

142

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27469493%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27469493%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

page(s)

2197-2207

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27469493%20AND%20SRC:MED&resulttype=core&format=json

Neoadjuvant chemotherapy for osteosarcoma of the extremity: long-term results of the Rizzoli's 4th protocol.

11 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00432-016-2210-8

High dose ifosfamide in combination with high dose methotrexate, adriamycin and cisplatin in the neoadjuvant treatment of extremity osteosarcoma: preliminary results of an Italian Sarcoma Group/Scandinavian Sarcoma Group pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-016-2210-8

Tumor size and prognosis in aggressively treated osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-016-2210-8

Prognostic factors in the survival of patients diagnosed with primary non-metastatic osteosarcoma with a poor response to neoadjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-016-2210-8

Prognostic factors in localized extremity osteosarcoma: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-016-2210-8

Telangiectatic osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-016-2210-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-016-2210-8

Telangiectatic osteogenic sarcoma:A review of twenty-eight cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-016-2210-8

Predictive factors of disease-free survival for non-metastatic osteosarcoma of the extremity: an analysis of 300 patients treated at the Rizzoli Institute

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-016-2210-8

Neoadjuvant chemotherapy with methotrexate, cisplatin, and doxorubicin with or without ifosfamide in nonmetastatic osteosarcoma of the extremity: an Italian sarcoma group trial ISG/OS-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-016-2210-8

Does the histological subtype of high-grade central osteosarcoma influence the response to treatment with chemotherapy and does it affect overall survival? A study on 570 patients of two consecutive trials of the European Osteosarcoma Intergroup

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-016-2210-8

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-016-2210-8

State-of-the-art approach for bone sarcomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-016-2210-8

Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-016-2210-8

Telangiectatic Osteosarcoma: Radiologic-Pathologic Comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-016-2210-8

Statistics in orthopaedic papers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-016-2210-8

Preoperative chemotherapy for osteogenic sarcoma:Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-016-2210-8

Protocol of surgical treatment of long bone pathological fractures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-016-2210-8

Scandinavian Sarcoma Group Osteosarcoma Study SSG VIII: prognostic factors for outcome and the role of replacement salvage chemotherapy for poor histological responders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-016-2210-8

Neoadjuvant chemotherapy for osteogenic sarcoma: results of a Cooperative German/Austrian study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-016-2210-8

Pathologic fracture does not influence local recurrence and survival in high-grade extremity osteosarcoma with adequate surgical margins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-016-2210-8

Telangiectatic osteosarcoma of the extremity: neoadjuvant chemotherapy in 24 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-016-2210-8

Neoadjuvant chemotherapy for high-grade central osteosarcoma of the extremity. Histologic response to preoperative chemotherapy correlates with histologic subtype of the tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-016-2210-8

Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-016-2210-8

Prognostic factors and outcomes for osteosarcoma: An international collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-016-2210-8

The effect of local extent of the tumor on prognosis in osteosarcoma

21 January 2018

1 reference

12 December 2020

Primary osteogenic sarcoma: pathologic aspects in 20 patients after treatment with chemotherapy en bloc resection, and prosthetic bone replacement

1 reference

12 December 2020

Treatment of osteosarcoma of the extremities with the T-10 protocol, with emphasis on the effects of preoperative chemotherapy with single-agent high-dose methotrexate: a Scandinavian Sarcoma Group study

1 reference

12 December 2020

Primary chemotherapy and delayed surgery for non-metastatic telangiectatic osteosarcoma of the extremities. Results in 28 patients

1 reference

12 December 2020

Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols

1 reference

12 December 2020

The surgical treatment of patients with osteosarcoma who sustain a pathologic fracture

1 reference

12 December 2020

Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities. Results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicin

1 reference

12 December 2020

Survival, prognosis, and therapeutic response in osteogenic sarcoma. The memorial hospital experience

1 reference

12 December 2020

Primary osteosarcoma in adults older than 40 years.

1 reference

12 December 2020

Telangiectatic osteosarcoma

1 reference

12 December 2020

Do pathological fractures influence survival and local recurrence rate in bony sarcomas?

1 reference

12 December 2020

Pediatric osteosarcoma: therapeutic strategies, results, and prognostic factors derived from a 10-year experience

1 reference

12 December 2020

A system for the surgical staging of musculoskeletal sarcoma

1 reference

12 December 2020

Telangiectatic osteogenic sarcoma. Improved survival with combination chemotherapy

1 reference

12 December 2020

Nonmetastatic osteosarcoma of the extremity: results of a neoadjuvant chemotherapy protocol (IOR/OS-3) with high-dose methotrexate, intraarterial or intravenous cisplatin, doxorubicin, and salvage chemotherapy based on histologic tumor response

1 reference

12 December 2020

Telangiectatic osteogenic sarcoma: a clinicopathologic study of 124 patients

1 reference

12 December 2020

Osteosarcoma chemotherapy effect: a prognostic factor

1 reference

12 December 2020

The radiological appearances of telangiectatic osteosarcoma. A study of 14 cases

1 reference

12 December 2020

Osteogenic sarcoma with clinically detectable metastasis at initial presentation

1 reference

12 December 2020

A system of staging musculoskeletal neoplasms

1 reference

12 December 2020

Increased survival, limb preservation, and prognostic factors for osteosarcoma

1 reference

12 December 2020

Prognostic factors for teenage and adult patients with high-grade osteosarcoma: an analysis of 240 patients

1 reference

12 December 2020

Telangiectatic osteogenic sarcoma

1 reference

12 December 2020

Prognostic factors in bone sarcomas

1 reference

12 December 2020

Pathologic fracture in osteosarcoma : prognostic importance and treatment implications

1 reference

12 December 2020

Tumor volume change as a predictor of chemotherapeutic response in osteosarcoma.

1 reference

12 December 2020

Weekly high-dose methotrexate and doxorubicin for osteosarcoma: the Dana-Farber Cancer Institute/the Children's Hospital--study III

1 reference

12 December 2020

Telangiectatic osteosarcoma: the St. Jude Children's Research Hospital's experience

1 reference

12 December 2020

Osteosarcoma of the extremities with synchronous lung metastases: long-term results in 44 patients treated with neoadjuvant chemotherapy

1 reference

12 December 2020

10.1007/S00432-016-2210-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27469493%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

1 reference